Mustang Bio, Inc. (MBIO)
0.4711
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
Mustang Bio EPS Diluted (Quarterly) : -0.1592 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1592 |
| March 31, 2026 | -0.1419 |
| December 31, 2025 | -0.0737 |
| September 30, 2025 | -0.075 |
| June 30, 2025 | -0.1895 |
| March 31, 2025 | -0.0535 |
| December 31, 2024 | -0.9495 |
| September 30, 2024 | -0.0383 |
| June 30, 2024 | -0.3546 |
| March 31, 2024 | -0.4613 |
| December 31, 2023 | -0.9345 |
| September 30, 2023 | -1.231 |
| June 30, 2023 | -1.998 |
| March 31, 2023 | -2.062 |
| December 31, 2022 | -2.744 |
| September 30, 2022 | -2.690 |
| June 30, 2022 | -2.783 |
| March 31, 2022 | -3.033 |
| December 31, 2021 | -3.185 |
| September 30, 2021 | -2.799 |
| June 30, 2021 | -2.460 |
| Date | Value |
|---|---|
| March 31, 2021 | -2.788 |
| December 31, 2020 | -4.833 |
| September 30, 2020 | -3.393 |
| June 30, 2020 | -4.863 |
| March 31, 2020 | -4.238 |
| December 31, 2019 | -6.041 |
| September 30, 2019 | -3.825 |
| June 30, 2019 | -4.296 |
| March 31, 2019 | -5.160 |
| December 31, 2018 | -6.394 |
| September 30, 2018 | -4.154 |
| June 30, 2018 | -2.820 |
| March 31, 2018 | -178.52 |
| December 31, 2017 | -8.920 |
| September 30, 2017 | -4.05 |
| June 30, 2017 | -3.15 |
| March 31, 2017 | -2.10 |
| December 31, 2016 | -9.60 |
| September 30, 2016 | -2.85 |
| June 30, 2016 | -1.65 |
| March 31, 2016 | -1.35 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
| Biogen, Inc. | 0.6557 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.072M |
| Total Expenses (Quarterly) | 1.072M |
| Enterprise Value | -11.58M |
| Earnings Yield | -95.48% |
| Normalized Earnings Yield | -95.48 |